These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23370991)

  • 21. Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.
    Musella A; Mandolesi G; Gentile A; Rossi S; Studer V; Motta C; Sepman H; Fresegna D; Haji N; Paolillo A; Matarese G; Centonze D
    J Neuroimmunol; 2013 Nov; 264(1-2):8-13. PubMed ID: 24045165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
    Jee Y; Piao WH; Liu R; Bai XF; Rhodes S; Rodebaugh R; Campagnolo DI; Shi FD; Vollmer TL
    Clin Immunol; 2007 Oct; 125(1):34-42. PubMed ID: 17632037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fumarates modulate microglia activation through a novel HCAR2 signaling pathway and rescue synaptic dysregulation in inflamed CNS.
    Parodi B; Rossi S; Morando S; Cordano C; Bragoni A; Motta C; Usai C; Wipke BT; Scannevin RH; Mancardi GL; Centonze D; Kerlero de Rosbo N; Uccelli A
    Acta Neuropathol; 2015 Aug; 130(2):279-95. PubMed ID: 25920452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
    Gilgun-Sherki Y; Panet H; Holdengreber V; Mosberg-Galili R; Offen D
    Neurosci Res; 2003 Oct; 47(2):201-7. PubMed ID: 14512144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.
    Gentile A; Musella A; De Vito F; Fresegna D; Bullitta S; Rizzo FR; Centonze D; Mandolesi G
    J Neuroinflammation; 2018 Jan; 15(1):5. PubMed ID: 29304807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutamate, T cells and multiple sclerosis.
    Levite M
    J Neural Transm (Vienna); 2017 Jul; 124(7):775-798. PubMed ID: 28236206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
    Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ; Hammond JW; Li H; Gantz Marker MA; Marker DF; Freeman RS; Gelbard HA
    eNeuro; 2018; 5(6):. PubMed ID: 30627663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis.
    Musella A; Gentile A; Guadalupi L; Rizzo FR; De Vito F; Fresegna D; Bruno A; Dolcetti E; Vanni V; Vitiello L; Bullitta S; Sanna K; Caioli S; Balletta S; Nencini M; Buttari F; Stampanoni Bassi M; Centonze D; Mandolesi G
    Cells; 2020 May; 9(5):. PubMed ID: 32455907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
    Lalive PH; Neuhaus O; Benkhoucha M; Burger D; Hohlfeld R; Zamvil SS; Weber MS
    CNS Drugs; 2011 May; 25(5):401-14. PubMed ID: 21476611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.
    Maier K; Kuhnert AV; Taheri N; Sättler MB; Storch MK; Williams SK; Bähr M; Diem R
    Am J Pathol; 2006 Oct; 169(4):1353-64. PubMed ID: 17003491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
    Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH
    J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ; Geathers JS; Allan KC; Gelbard HA
    J Neurosci; 2016 Jan; 36(4):1336-46. PubMed ID: 26818520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis.
    Rossi S; Lo Giudice T; De Chiara V; Musella A; Studer V; Motta C; Bernardi G; Martino G; Furlan R; Martorana A; Centonze D
    Br J Pharmacol; 2012 Feb; 165(4):861-9. PubMed ID: 21740406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis.
    Aharoni R; Herschkovitz A; Eilam R; Blumberg-Hazan M; Sela M; Bruck W; Arnon R
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11358-63. PubMed ID: 18678887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glatiramer acetate treatment increases stability of spinal synapses and down regulates MHC I during the course of EAE.
    Scorisa JM; Freria CM; Victorio SC; Barbizan R; Zanon RG; Oliveira AL
    Int J Biol Sci; 2011; 7(8):1188-202. PubMed ID: 22043176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis.
    Burger D; Molnarfi N; Weber MS; Brandt KJ; Benkhoucha M; Gruaz L; Chofflon M; Zamvil SS; Lalive PH
    Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4355-9. PubMed ID: 19255448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate.
    Begum-Haque S; Christy M; Ochoa-Reparaz J; Nowak EC; Mielcarz D; Haque A; Kasper LH
    J Neuroimmunol; 2011 Mar; 232(1-2):136-44. PubMed ID: 21111489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glatiramer acetate biases dendritic cells towards an anti-inflammatory phenotype by modulating OPN, IL-17, and RORγt responses and by increasing IL-10 production in experimental allergic encephalomyelitis.
    Begum-Haque S; Christy M; Wang Y; Kasper E; Ochoa-Reparaz J; Smith JY; Haque A; Kasper LH
    J Neuroimmunol; 2013 Jan; 254(1-2):117-24. PubMed ID: 23141166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunomodulator glatiramer acetate influences spinal motoneuron plasticity during the course of multiple sclerosis in an animal model.
    Marques KB; Scorisa JM; Zanon R; Freria CM; Santos LM; Damasceno BP; Oliveira AL
    Braz J Med Biol Res; 2009 Feb; 42(2):179-88. PubMed ID: 19274346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.